(INNS)
ANSELAMIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS IMMUNOGLOBULIN LIGHT CHAIN AMYLOID (AL) FIBRILS], CHIMERIC MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN CHIMERIC (1-441) [MUS MUSCULUS VH (IGHV2-3*01 (92.6%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [8.7.5] (26-33.51-57.96-100)) (1-111) -HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1 (CH1 R120 (208) (112-209), HINGE 1-15 (210-224), CH2 (225-334), CH3 E12 (350), M14 (352) (335-439), CHS (440-441)) (112-441)], (214-219')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-219') [MUS MUSCULUS V-KAPPA (IGKV1- 110*01 (95.0%) -IGKJ1*01 (100%), CDR-IMGT [11.3.9] (27-37.55-57.94-102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219')]219')]; DIMER (220-220'':223-223'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-DG44 CELL LINE, GLYCOFORM ALFA(WHO)
ANSELAMIMABUM(INN)